ENGN
enGene Holdings Inc. Common Stock
NASDAQ: ENGN · HEALTHCARE · BIOTECHNOLOGY
$7.27
+3.27% today
Updated 2026-04-30
Market cap
$535.25M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.25
Dividend yield
—
52W range
$3 – $12
Volume
0.4M
enGene Holdings Inc. Common Stock (ENGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | — | $131.45M | $132.04M | $86.96M | $311.17M | $221.47M |
| Cash & equivalents | — | $1.07M | $314151.00 | $81.52M | $173.00M | $50.15M |
| Current assets | — | $1.57M | $511804.00 | $85.44M | $247.36M | $201.39M |
| Total liabilities | — | $4.05M | $4.62M | $14.47M | $38.56M | $53.76M |
| Current liabilities | — | $327447.00 | $893509.00 | $5.26M | $14.66M | $31.98M |
| Long-term debt | — | $3.05M | $30.84M | $9.22M | $22.47M | $15.32M |
| Shareholder equity | — | $127.39M | $127.42M | $72.49M | $272.61M | $167.71M |
| Retained earnings | — | $-2.28M | $-4.11M | $-199.59M | $-254.73M | $-372.03M |
| Accounts receivable | — | $1.62M | $1.34M | $2.34M | $1.03M | $2.23M |
| Inventory | — | $81000.00 | $74000.00 | $76000.00 | — | — |
| Goodwill | — | — | — | — | — | — |